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https://doi.org/10.1016/j.stemcr.2021.02.020SUMMARYHematopoiesis serves as a paradigm for how homeostasis is maintained within hierarchically organized cell populations. However,
important questions remain as to the contribution of hematopoietic stem cells (HSCs) toward maintaining steady state hematopoiesis.
A number of in vivo lineage labeling and propagation studies have given rise to contradictory interpretations, leaving key properties of
stem cell function unresolved. Using processed flow cytometry data coupled with a biology-driven modeling approach, we show that
in vivo flux experiments that come from different laboratories can all be reconciled into a single unifying model, even though they
had previously been interpreted as being contradictory. We infer from comparative analysis that different transgenic models display
distinct labeling efficiencies across a heterogeneous HSC pool, which we validate by marker gene expression associated with HSC func-
tion. Finally, we show how the unifiedmodel of HSC differentiation can be used to simulate clonal expansion in the early stages of leuke-
mogenesis.INTRODUCTION
More than a century of sustained research efforts has estab-
lished hematopoiesis as a paradigm for adult stem cell
biology (Laurenti and Göttgens, 2018; Pappenheim,
1896). Sophisticated transplantation assays have pin-
pointed the key stem cell properties of self-renewal and
multilineage differentiation capacity to a rare population
of cells, present at a frequency of approximately 1 in
20,000 in mouse bone marrow (Seita and Weissman,
2010; Spangrude et al., 1988). Coupling transplantation
with flow-cytometric cell sorting established an experi-
mentally tractable differentiation hierarchy from hemato-
poietic stem cells (HSCs) via multipotent progenitors
(MPPs) toward the individual blood lineages. Moreover,
the initially defined HSC population was subsequently
shown to be separable into long-term HSCs and short-
term HSCs (ST-HSCs), of which only the former has true
long-term (over 20 weeks) transplant reconstitution capac-
ity, as well as the ability to maintain stem cell function
through serial transplantation (Laurenti and Göttgens,
2018).
The high turnover of the blood system necessitates the
constant production of large numbers of new blood cells.
Pioneering transplant experiments following exposure to
the chemotherapy agent 5-fluorouracil revealed that aStem Ce
This is an open access artipool of slowly cycling stem/progenitor cells exists up-
stream of faster cycling MPPs (Hodgson and Bradley,
1979). More recent experiments have established that
those mouse HSCs with the most robust transplant ability
tend to be the most quiescent HSCs (Oguro et al., 2013),
with rates of cell division estimated to be less than once
per 100 days (Wilson et al., 2008). Collectively, these
studies raised the question as to how important HSCs are
for native, unperturbed hematopoiesis, regardless of the
undoubtedly pivotal role they play in transplant settings
(Höfer and Rodewald, 2018). Transposon-based transgenic
mouse models permit the labeling of individual stem/pro-
genitor clones, and subsequently track how individual
clones contribute to mature hematopoietic lineages over
time. Using this approach, it was argued that long-lived
progenitors, rather than classically defined HSCs, are the
main drivers of unperturbed hematopoiesis (Sun et al.,
2014). However, the technology could suffer from low
sensitivity to detect clones within the HSC compartment,
particularly those that divide rarely.
Several groups therefore embarked on label-propagation
studies, where recombinase-mediated activation of fluores-
cent reporter genes creates a genetic label exclusively in
HSCs (Busch et al., 2015), or in HSCs and, to a minor
extent, intermediate progenitors (Chapple et al., 2018; Sa-
wai et al., 2016; Säwén et al., 2018). The genetic label canll Reports j Vol. 16 j 741–753 j April 13, 2021 j ª 2021 The Authors. 741
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be followed when HSCs enter differentiation to contribute
to the various blood cell lineages. These four separate
studies reported conflicting conclusions, ranging from
minor to substantial contributions of HSCs to native hema-
topoiesis. Of note, one of the studies (Sawai et al., 2016)
employed a strategy that entailed serial sampling of the
same mouse, whereas the other three studies (Busch
et al., 2015; Chapple et al., 2018; Säwén et al., 2018) uti-
lized the same experimental design of using unique mice
for each time point, thus facilitating direct comparisons.
Two of the four studies inferred the differentiation rates
of HSCs and MPP cells by constructing mathematical
models, built from the quantitative measurements of the
speed at which the genetic label progresses down the he-
matopoietic hierarchy. Although the two studies inferred
a similar order of magnitude for HSC output, around 1%
(Busch et al., 2015) to 3% (Sawai et al., 2016) of HSCs per
day giving rise to ST-HSCs, Sawai et al. (2016) found no
self-renewing progenitors downstream of HSCs, calling
for a major role for HSCs in sustaining hematopoiesis.
Furthermore, some key assumptions for model construc-
tion were different (Pucella et al., 2020).
In this study, we set out to resolve the different conclu-
sions reported by the comparable lineage-tracing studies
by using published data from the different groups. Direct
comparison of labeled and unlabeled cell counts over
time revealed clear qualitative and quantitative differences
(see Results and Figures 1B and 1C), which we reasoned
were due to the use of different transgenic Cre models.
We therefore adopted a modeling approach that accounts
for differences in label induction across a heterogeneous
stem cell compartment (Barile et al., 2020). Importantly,
this allowed us to define a single set of inferred kinetic
properties that can explain training as well as validation
datasets, thus demonstrating true predictive capability. As
a result, we show how previous claims of contrasting
degrees of HSC contribution to unperturbed hematopoiesis
can be readily reconciled. Our study therefore provides a
unified quantitativemodel for unperturbed hematopoiesis,
which we furthermore exploit to interrogate the relation-
ship between oncogene strength and target cell for trans-
formation during the early stages of leukemogenesis.RESULTS
Fgd5 and Tie2 (Tek) Cre Knockin Elicits Qualitatively
Different Label Propagations
Two recent lineage-tracing studies employed inducible Cre
knockin alleles driven by Fgd5 (Gazit et al., 2014; Säwén
et al., 2018) and Tie2 (Busch et al., 2015) regulatory ele-
ments to quantify label propagation across the hematopoi-
etic hierarchy under unperturbed settings (Figure 1A). Both742 Stem Cell Reports j Vol. 16 j 741–753 j April 13, 2021studies used flow cytometry to assess label propagation
over an extended time course, Busch et al. (2015) inferring
anHSC rate of differentiation into ST-HSCs of about 1%per
day, whereas Säwén et al. (2018) suggested a more active
HSC contribution, but without quantification. Given the
central importance of this debate for the wider field of
hematopoiesis, we set out to assess how these different con-
clusions may have arisen. We focused on the most imma-
ture populations in the hematopoietic hierarchy, namely
LSK CD150+ CD48 HSCs, LSK CD150 CD48 ST-HSCs,
and LSK CD150 CD48+ MPPs.
A direct comparison of the labeling frequency over time
showed a faster accumulation of labeled cells in several
downstream compartments (Figure 1B) for the Fgd5
dataset. With the temporal dynamics of label propagation
clearly different between the two datasets, we next asked
whether the steady-state model of hematopoiesis devel-
oped for the Tie2 dataset (Busch et al., 2015) could also
explain the temporal dynamics observed in the Fgd5
experiment (Säwén et al., 2018). The model describes
stem and progenitor cell population dynamics, based on
two parameters per population: the differentiation rate,
i.e., the frequency at which progeny are produced from a
progenitor, and the residence time, a measurement of a
population’s self-renewal degree. Deriving these parame-
ters from the two different datasets resulted in substantially
different values (Figure 1C). For example, the derived
differentiation rate of HSCs for the Fgd5 dataset was higher
than for the Tie2 dataset. Moreover, while a population
downstream of HSCs with high self-renewal capability
was inferred for both datasets, this comprised MPPs in
Säwén et al. (2018) and ST-HSCs in Busch et al. (2015).
These analyses suggest that the underlying biology
captured by the Fgd5 versus the Tie2 Cre model is distinct
and that the steady-state model is of limited applicability.
Moreover, the steady-statemodel did not provide a satisfac-
tory fit to the Fgd5 dataset (Figure S1A), whereas it did for
the Tie2 dataset, suggesting that a non-steady-state model
(Barile et al., 2020) is required for a unified description of
both datasets.
Existing Models Do Not Address Key Aspects of Stem
Cell Behavior
Computational modeling has played a pivotal role in efforts
to infer stem cell kinetics and has uncovered properties of
stem cells that could otherwise not have been deduced
from static analysis of the data alone (Buchholz et al.,
2013; Foudi et al., 2009; Mackey, 2001; van der Wath et al.,
2009).However, our analysis in the previous section showed
that the approaches taken previously to model HSC label
propagation lack the flexibility to explain more than a
single experimental dataset. The mathematical model in
Busch et al. (2015) assumes that the flow-cytometric HSC
A
B C
Figure 1. Published Label-Propagation Results with Tie2 and Fgd5 Cre Mouse Models Are Qualitatively Different
(A) Outline of tamoxifen-inducible Cre recombination-based fate-mapping experiments to analyze stem cell kinetics. Healthy transgenic
mice are injected with tamoxifen, which causes labeling of the HSC population. Circles represent stem cell populations with the proportion
of labeled cells shown in red. Label propagates over time and appears sequentially in downstream populations.
(B) Frequency of labeled cells in the ST-HSC and MPP compartments scaled to the labeling frequency in HSCs, following a uniform pipeline
for flow cytometry data processing applied to data from Busch et al. and Säwén et al. Bars represent average and SEM at comparable time
points (n = 104 or n = 48, respectively, for the three time points altogether, all independent experiments).
(C) Model parameters of kinetic rates as inferred by the basic steady-state model developed for Busch et al. Best-fit value and the 95%
profile likelihood confidence bounds are shown. Non-overlapping bounds highlight that this approach fails to find consistent parameters
between the two studies. ⍺, differentiation rates; k, measure of self-renewal, with smaller k’s representing higher self-renewal in a
compartment. Blue dots are computed parameters for Fgd5 dataset, red for Tie2 dataset.population is homogeneous and characterized by uniform
cell kinetic rates,while amore recent extensionof thismodel
accounts for HSC and ST-HSC population heterogeneity
(Barile et al., 2020). Whereas the former model cannot ac-
count for the increase over a time span of 2 years in the fre-
quency of labeledHSCs, observed in all lineage-tracing data-
sets (data not shown), the latter model does. Given that Creinduction occurred only at the beginning of the time course,
the most likely explanation for a subsequent increase in the
proportion of labeled cells in the flow-cytometricHSCpopu-
lation is that this population is heterogeneous, where a sub-
populationdisplayshigher labeling frequency right fromthe
start, which subsequently propagates to the rest of the popu-
lation. Moreover, the homogeneity assumption of theStem Cell Reports j Vol. 16 j 741–753 j April 13, 2021 743
simple steady-state model prevents the model from fitting
theplateauof ST-HSCnormalized label frequency.Withaho-
mogeneous HSC population, this frequency is expected to
converge to 1, but as observed in the Fgd5 dataset (Fig-
ure S1A), the frequency tails off at around 0.7.
Another simplification of the published models is the
assumption of a steady state in Busch et al. (2015) and Sawai
et al. (2016) with constant compartment sizes and rates dur-
ing amouse’s life. Barile et al. (2020) and Bernitz et al. (2016)
show that several populations, including the HSC popula-
tion, change substantially with aging along extended time
courses (see Figure S1B). Finally, the assumption of time-in-
dependent rates does not consider the decrease in stem cell
output upon aging (as observed by Säwén et al., 2018, and
Barile et al., 2020). As the overarching purpose of modeling
is the derivation of biologicallymeaningful conclusions that
are statistically supported by all the available experimental
data, we asked whether the Tie2 and Fgd5 datasets could
be reconciled by an extended non-steady-state model with
HSC heterogeneity.
HSC Population Heterogeneity Suffices to Explain
Quantitative Differences When Using Fgd5 and Tie2
Cre Drivers
Heterogeneity within flow-cytometric HSC populations
has long been recognized and explored experimentally by
several groups (Oguro et al., 2013; Sawai et al., 2016; Wil-
son et al., 2008). HSC heterogeneity has also been consid-
ered in tissue models (Roeder and Loeffler, 2002), but so
far has not been used to integrate different label-propaga-
tion experiments. We therefore investigated whether
quantitative differences between the Fgd5 and the Tie2
label-propagation datasets could be explained by a hetero-
geneous HSC population, where the subpopulations are
labeled with different probabilities by the Fgd5 versus the
Tie2 Cre. Figure 2A illustrates this concept with a toy
model. Let us assume that HSCs are split into two subcom-
partments (upstream [HSC-U] and downstream [HSC-D]).
If two different Cre drivers (label I and label J) were to label
the upstream and downstream subcompartments 50% and
0% versus 50% and 50%, respectively, then the time-
dependent accumulation of labeled cells in population
ST-HSC would be qualitatively different, even though the
kinetic parameters of all the populations are the same.
We thus adopted the idea of a heterogeneous HSC popu-
lation and dropped the steady-state assumption. To satisfy
the constant rate assumption, we narrowed the observa-
tion window to 40 weeks, thus excluding the major
aging-related alteration in population abundance within
the extended time-course datasets.
This new model was fit to both the Fgd5 and the Tie2
datasets (both the frequency and the population size
data) simultaneously to infer common underlying kinetics,744 Stem Cell Reports j Vol. 16 j 741–753 j April 13, 2021but permitting different initial labeling frequencies for
each population. Themodel fit provided a good description
of the input data, withmost points lying within the predic-
tion profile likelihood (Kreutz et al., 2012) confidence
bounds (Figure 2B) for both label frequency and compart-
ment population size. Modeled population sizes over
time revealed substantial confidence bounds for the in-
ferred most immature HSC population, which was pre-
dicted to expand (Figure S2). Of note, all estimated param-
eters have at least one identifiable bound, so the model is
not overfitted (Murray 2002; Raue et al., 2009). Even
though the datasets appear to infer different biological
properties at first glance, both datasets are consistent
with a single set of stem cell kinetics as long as differences
in the initial Cre-mediated labeling are considered.
In particular, the key difference inferred by the model re-
lates to different labeling of the HSC subcompartments
with the Tie2 and Fgd5 Cre knockin mice (Figure 3B).
The inferred ratio of initial labeling frequency between
HSC-U and HSC-D (Figure 3C) is at least 4:1 for Fgd5 and
21:1 for Tie2. Consequently, Tie2 Cre-mediated labeling is
inferred to be at least 4.8 times more specific to HSC-U
than the Fgd5 Cre-induced label. Intuitively, this suggests
that with Fgd5 Cre, labeled cells from HSC populations as
defined by flow cytometry will progress faster to the ST-
HSC population because of the relatively higher HSC-D
labeling frequency, since HSC-D is ‘‘closer’’ to ST-HSC
than HSC-U.
Taken together, our results suggest that different initial
labeling frequencies of a heterogeneous HSC population
are sufficient to explain the observed differences between
Fgd5 and Tie2 Cre-induced label-propagation studies.
Importantly therefore, both studies are consistent with a
common and unified set of underlying stem cell kinetics.
The Unified Stem Cell Kinetics Inferred for the Tie2
and Fgd5 Datasets Explain a Third Independent
Fate-Mapping Experiment
The initial requirement for any model designed for
experimental data is that it accurately captures a set of
experimental observations. However, a stringent test of
the predictive power of a computational model is its appli-
cation to an independent experiment that did not form
part of the training data. We therefore used the same flow
cytometry processing pipeline to analyze a third indepen-
dent lineage-tracing/label-propagation study from Chap-
ple et al. (2018). This study used a Cre transgene exploiting
gene regulatory sequences of the Krt18 gene locus to drive
expression of an inducible Cre transgene in the HSC
compartment. Importantly, this allowed us to validate
the idea that different initial labeling frequencies of stem
cells, particularly of a heterogeneous HSC population, are




Figure 2. Different Initial Labeling of HSC Subcompartments Explains the Qualitative Differences among Datasets
(A) Concept illustrated by a toy model. Left: a differentiating cascade with a stem cell population of HSCs producing progeny ST-HSCs. HSCs
are heterogeneous, but treated as homogeneous due to the lack of markers to distinguish the subcompartments. HSC-U, upstream; HSC-D,
downstream. Two hypothetical Cres, I and J, label the upstream and downstream compartments with different proportions. Right: the
simulated accumulation of labeled cells in ST-HSC, normalized to the labeling frequency of HSCs considered as homogeneous, is
qualitatively different for labels I and J, although the underlying population kinetics are the same.
(B) Model best fit (solid line) and 95% prediction profile likelihood confidence bounds on the model (shaded area) plotted against
the experimental data (big dots representing average and SEM of datasets, small dots the mice from independent experiments, n = 242 or
(legend continued on next page)
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different studies, with all stem/progenitor cell kinetics re-
maining fixed (and thus the same) across all three studies.
Stem cell kinetics from the joint analysis of the Fgd5 and
Tie2 datasets were fixed, and only the initial labeled fre-
quencies were trained on the new Krt18 data points (Fig-
ure 3A). This modeling approach provided a good fit for
the Krt18 dataset, thus not only demonstrating the predic-
tive power of our model, but also emphasizing the notion
that a single set of stem/progenitor cell kinetics is compat-
ible with multiple label-propagation studies, which at first
glance appeared to present highly contradictory results.
Indeed, Chapple et al. (2018) had concluded, although
without quantification, that the HSC population is active,
in line with Säwén et al. (2018), but in contrast to Busch
et al. (2015). Our analysis suggests that there is no need
to assume any one of these studies to be incorrect. Instead,
the supposed discrepancies can be reconciled by a revised
interpretation of the properties of the data, which impor-
tantly is based on a single set of assumptions about the un-
derlying biological properties of the stem cells.
The Unified Model Predicts Inactive and Active HSC
Subpopulations and Sustained Self-Renewal
Downstream of HSCs
Our new approach for studying unperturbed hematopoie-
sis faithfully captures experimental label-propagation ex-
periments from three different groups using three different
Cre drivers. We were therefore interested to explore further
the model parameters (Figure 2C), as they should have a
significantly higher chance of capturing the true biology
of unperturbed hematopoiesis than previous modeling ef-
forts that, as we showhere, cannot explainmore than a sin-
gle dataset. Themodel predicted an inactive near-quiescent
upstream HSC-U population with around 1 in 50 HSC-U
cells differentiating per week, and an active HSC-D popula-
tion with each HSC-D cell differentiating every week, thus
suggesting that at least a subset of HSCs contributes
frequently to normal hematopoiesis, as emerged qualita-
tively from the Fgd5 dataset. On the other end, we identi-
fied MPPs as an almost self-renewing population (high
residence time, low k value), consistent with a key role
for progenitors downstream of HSCs in supplying fresh
blood cells in steady-state hematopoiesis as well as
in situations where stem cell input may be lacking (Schoe-
del et al., 2016; Sheikh et al., 2016). Of note, while then = 48, respectively, for Tie2 and Fgd5 datasets for all three plots). The
later time points have different numbers of samples, reflected in the l
qualitatively different between the two datasets due to the different
data, measured at common time points. Labeled frequencies of ST-HSC
of HSCs.
(C) Best-fit model parameters trained on the two datasets, shown al
differentiation rate of HSC-D is high, suggesting a major contribution
746 Stem Cell Reports j Vol. 16 j 741–753 j April 13, 2021model gives a clear indication of self-renewal downstream
of HSCs, which subpopulations are identified as self-renew-
ing may depend on the potential heterogeneity of the ST-
HSC and MPP compartments.
Our model therefore reconciles the various headline
statements from studies previously regarded as contradic-
tory. Cells within the HSC pool readily contribute to hema-
topoiesis, but the model also shows that non-stem progen-
itor populations can have prominent roles in sustaining
hematopoiesis. Overall, the parameters suggest that a sub-
compartment of the HSC population is indeed producing
differentiated cells frequently, although downstream pro-
genitors have a sufficient degree of self-renewal to cope
with prolonged stem cell failure.
Inferred HSC Labeling Patterns Agree with SCA1
Surface Marker Expression
As outlined above, the new model has a constant set of ki-
netic parameters but assumes that (1) the HSC population
is composed of two hierarchically connected subpopula-
tions, and (2) the different Cre drivers label cells in the
two subcompartments with different proportions. The in-
ferred ratios of labeling frequencies for HSC-U and HSC-D
for the three Cre drivers are at least as follows: 4:1 for
Fgd5, 21:1 for Tie2, and 30:1 for Krt18 (Figures 3B and
3C). To test these inferred proportions, we investigated
the fluorescence-activated cell sorting intensities of the
SCA1 surface marker for labeled and unlabeled HSCs (Fig-
ures 3D and S3). Previous studies have shown a link be-
tween SCA1 expression levels and the reconstitution po-
tential of the HSC population after transplantation
(Wilson et al., 2015), with SCA1high cells providing more
robust and durable long-term reconstitution than SCA1lo
cells. SCA1high cells are thus thought to account for the
long-term reservoir of dormant HSCs (Sawai et al., 2016;
Wilson et al., 2008).
Fortuitously, Chapple et al. (2018) reported lineage propa-
gation data not just for the Krt18 Cre, but also for the same
Fgd5 Cre (as used by Säwén et al., 2018). This allowed us to
perform robust quantitative comparisons of flow cytometry
intensities, which would be rather challenging to perform
on datasets generated by different groups using different
machines. This comparative analysis demonstrated that
HSCs labeled with Krt18 have higher SCA1 levels compared
with unlabeled HSCs, while SCA1 expression of HSCsvariance was pooled for all data points to account for the fact that
arger confidence bounds on parameters and model. Kinetics appear
initial labeling frequencies. Data are an average of all the available
and MPP populations have been normalized to the labeled frequency
ongside 95% prediction profile likelihood confidence bounds. The
to hematopoiesis, although the confidence bounds are also large.
Figure 3. Investigation of Model Parameters Gives Insights into Cre Labeling Marker Bias and Stem Cell Kinetics
(A) Predicting an independent experiment from the learned kinetics. Upon changing only the initial labeling frequency in the HSC-U and
HSC-D populations, an independent experiment can be predicted with the best-fit kinetics learned from the previous two datasets. Blue
line, best fit for the Fgd5 dataset. Green, best fit (solid line) and 95% profile likelihood confidence bounds (shading) on the model for the
Krt18 datasets. Big dots represent average and SEM of dataset, small dots the mice from independent experiments, n = 54 for all three plots.
(legend continued on next page)
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labeled with Fgd5 spills over to the lower-intensity peaks,
and thus overlaps more broadly with the unlabeled HSCs.
Given the knownassociation of themost robust and durable
transplantable HSCs with high levels of SCA1, this result is
consistent with our inferred differential labeling efficiencies
for the Krt18 and Fgd5 Cre drivers, since the modeling had
inferred that Krt18 Cre would show higher labeling speci-
ficity for the most upstream HSC subpopulation. This
analysis therefore provided experimental validation and
corroboratedour approachof inferring values for differential
HSC labeling patterns across a heterogeneous HSC compart-
ment. Moreover, these findings highlight the notion that
opposing conclusions drawn from the various label-propa-
gation studies are indeed a likely consequence of different
biological properties of the various Cre drivers.Modeling Leukemia Development Kinetics Based on
Cell of Origin
A model describing the kinetics of stem cells can be used to
give insights into disorders that arise in stem or progenitor
cells. Since our combinedmodel appears robust in capturing
biological features of normal hematopoiesis, we were inter-
ested to see whether the model could also be used to simu-
late the early steps of malignant transformation toward
leukemia. More specifically, we wanted to interrogate the
potential dependence of leukemic progression on the popu-
lation where the mutation first arises. Leukemogenesis
commonly develops as a stepwise process, where preleuke-
mic clones show normal differentiation into all the mature
lineages, yet have a so-called clonal advantage, whereby
the clone expands as a fraction of the entire system over
time. Within our model, this process can be investigated
by tuning the parameters inferred for normal hematopoiesis
to simulate the emergence of a malignant cell, and then
simulating how this ‘‘clone’’ behaves over time.
Based on the population kinetics from our new combined
model, we first investigated how a mutant stem cell with
enhanced proliferation would cause an accumulation of
the progeny of this mutant clone into the MPP compart-
ment (Figure 4A). Given the active debate on whether ST-
HSCs and/or MPPs can serve as cells of origin for leukemia
development, we also simulated the emergence of individ-
ual mutant clones in these cell populations. For modeling(B) Model-predicted initial labeling frequencies for each stem cell pop
by different amounts, leading to an observable difference in the temp
(C) Model-predicted initial labeling frequency ratios of HSC-U to HSC-
labeling frequency to initial HSC-D labeling frequency for each Cre driv
Cre drivers. It can be interpreted as the specificity of a Cre driver to HS
with dotted line indicating unbounded parameter.
(D) SCA1 expression-density plots for HSCs in Fgd5 and Krt18 fate-m
between labeled and unlabeled HSCs for each reporter gene at the fir
748 Stem Cell Reports j Vol. 16 j 741–753 j April 13, 2021purposes, we assumed that the initial mutation would
endow the target cell and all of its daughter cells with an
increased proliferative potential, and thus tested prolifera-
tion rate increases by factors of 31.03 (a weak mutation),
31.08 (a moderate mutation), and 31.15 (a strong muta-
tion). Following themodel for a 60week time course showed
that leukemic clone establishment was dependent on both
the cell of origin and the strength of the mutation (Fig-
ure 4B). ‘‘Weak’’ oncogenic mutations in the upstream cell
populations, namely HSC-D and HSC-U, result in the estab-
lishment of the leukemic clone, but ‘‘weak’’ oncogenic mu-
tations originating in the downstream cell populations are
diluted out and are insufficient to promote preleukemic
development. By contrast, ‘‘strong’’ mutations are sufficient
to cause clonal expansion, regardless of the cell of origin.
We next identified the threshold of mutation strength
required to generate an expanding clone starting from
the four cell types contained within our model. We found
that a mutation in all cell populations can induce an
immortal mutant clone population in the MPP compart-
ment (Figure 4C), but again, the ease with which this is
achieved is dependent on the cell population. For HSC-U,
any increase in proliferation is enough, for HSC-D an in-
crease of 31.04 is required, and for ST-HSC and MPPs,
this value is 31.06. The relationship between mutation
strength and cell of origin extended all the way to the
two HSC subpopulations. In terms of potential mecha-
nisms, these findings suggest that a very weak oncogenic
mutation in the HSC population is sufficient to cause
mutant cells flowing into the MPP population to balance
the loss of mutant cells due to further differentiation. How-
ever, a stronger oncogenic mutation is required to create a
similar immortal mutant MPP population if the initiating
mutation arises within theMPP themselves. From a clinical
perspective, our results serve as a potential explanation of
how leukemic clones with identical mutations may exhibit
different levels of ‘‘fitness’’ depending on their cell of
origin, and thus may respond differently to treatment.DISCUSSION
Recent advances in lineage tracing and genomic technolo-
gies are ushering in a new era of stem cell biology, with theulation. The three Cre drivers are predicted to label each population
oral dynamics. Error bars show confidence intervals for parameters.
D. Left side shows the minimum value for the ratio of initial HSC-U
er. Right side shows the ratio of these ratios between the different
C-U over HSC-D. Error bars show confidence intervals for parameters
apping experiments. Plots show a comparison of the distribution




Figure 4. Modeling Cell of Origin Reveals
Distinct Leukemogenesis Dynamics
(A) Model to investigate propagation of
single cell mutation from each stem cell
population dependent on the factor by
which cell proliferation increases. A single
cell mutation in one population propagates
to progeny populations over time. Whether
the mutation population develops is
dependent on population of origin and de-
gree of increase in self-renewal (i.e.,
strength of mutation).
(B) Simulation of leukemogenesis dynamics
over 60 weeks compared by mutant cell
origin. Plots show proportion of MPP cells
that are mutants (have higher proliferation
rates). A strong mutation in any stem cell
population causes an overshoot of mutants
in the MPP population (red). However, the
effect of a weak/moderate mutation is
highly dependent on cell of origin (orange,
yellow).
(C) Simulation of leukemogenesis dynamics
to induce immortal mutant MPP population.
Immortal population can be induced by any
stem cell population, but the strength of
mutation required is highly dependent on
mutant origin. Bars show the fold increase
of the proliferation rate in each population
with respect to its normal haematopoisis
value.goal of defining stem cell/progeny relationships at both the
cellular and the molecular level. It is widely expected that
the resulting deep understanding of stem cell differentia-
tion trajectories will provide a blueprint to better under-
stand perturbations that drive stem cell diseases, as well
as informing the development of directed differentiation
protocols to produce the desired cell types for either drug
discovery or cellular therapy. However, vastly different con-
clusions have been drawn from the initial label-propaga-
tion studies performed using HSC-specific (Busch et al.,2015) and HSC- and ST-HSC/MPP-specific (Chapple et al.,
2018; Sawai et al., 2016; Säwén et al., 2018) Cre driver
mousemodels. Our study presents an approach that recon-
ciles the different studies, provides insights into what
caused the divergent interpretations, and demonstrates
how a refined computational model anchored in biology
can be utilized to quantify aberrations in cellular function
that may drive the early stages of leukemogenesis.
Wewould argue that the problem that we have addressed
here is broadly relevant to all areas of biology whereStem Cell Reports j Vol. 16 j 741–753 j April 13, 2021 749
modeling is employed to develop a useful abstraction of the
underlying processes. For our comparisons between data-
sets, we took account of three levels, namely a qualitative
description of the data, quantitative interpretation, and
the inferred biological mechanisms. Comparisons based
on qualitative or quantitative descriptions alone can fail
to identify fundamental similarities in the underlying bio-
logical mechanism, particularly because models are only
accurate descriptions of our thinking (Gunawardena,
2014). Similarly, the same biological mechanism can man-
ifest itself in different qualitative and quantitative descrip-
tions. Fitting both datasets at the same time allowed us to
counteract these problems and to focus on the underlying
biological mechanism. Just as we were able to reconcile the
different studies on HSC activity, we believe that this
approach may be useful to develop a consensus view in
other areas of biomedical research where computational
modeling applied to individual datasets has produced
divergent conclusions.
The delineation of the initial versions of the hematopoi-
etic differentiation tree represents one of the most signifi-
cant accomplishments of stem cell research in the last
two decades of the 20th century (Akashi et al., 2000; Kondo
et al., 1997). Subsequent refinements have split many of
the original populations into defined subpopulations,
such as MPP1-4 for the MPPs (Adolfsson et al., 2005; Cabe-
zas-Wallscheid et al., 2014; Pietras et al., 2015;Wilson et al.,
2008). Functional assays have also revealed heterogeneity
within the HSC population, for example, by identifying
HSCs with particularly potent and durable reconstitution
activity based on high SCA1 or medium KIT expression
(Grinenko et al., 2014; Wilson et al., 2015). We reasoned
that Cre drivers under the control of different regulatory se-
quences would differ in their relative labeling of HSCs
across this spectrum of heterogeneous function, and that
in turn such differential labeling could explain differences
in the observed stem cell kinetics. Importantly, we vali-
dated differential labeling of SCA1-high HSCs by two of
the transgenic cassettes, thus providing experimental
evidence for our modeling approach, which was able to
reconcile different studies based on differential labeling
of a heterogeneousHSC compartment. The flux parameters
for our unifying model predicted a near-quiescent HSC-U
population and an active HSC-D population. There is
both prior experimental and theoretical evidence support-
ing our approach (Bernitz et al., 2016; Glauche et al., 2007;
Morita et al., 2010; van der Wath et al., 2009; Wilson et al.,
2008). HSCs have commonly been divided into two popu-
lations based on either reconstituting capacity (Morita
et al., 2010) or cell-cycle status (van der Wath et al., 2009)
or a combination of the two (Oguro et al., 2013).
Ourmodel is in general agreementwith the size and char-
acteristics of the subcompartment structure proposed by750 Stem Cell Reports j Vol. 16 j 741–753 j April 13, 2021previous studies. In particular, it suggests that the upstream
HSC population is at least five times smaller than the
downstream HSC population, in agreement with the idea
of a hematopoietic hierarchy where the relative size of pro-
genitor populations tends to increase as one progresses
down the hierarchy (Busch et al., 2015; Sawai et al.,
2016). Attempts to define heterogeneous subcompart-
ments with lineage tracing have already been made (Barile
et al., 2020). However, with the data currently available,
the upstream HSC population still shows an increase in
labeled cells over time, indicating that there is further pop-
ulation heterogeneity that is not yet resolved with
commonly used markers. As a result, there is no consensus
on whether the HSC population should be split into two or
three, or, in the new era of single cell biology, whether we
should even think of discrete subcompartments any
longer. Nevertheless, our model shows that current experi-
mental data can be well explained by considering two HSC
subcompartments, whereby a minimal topology model
that connects all populations can explain the data while
being constrained using bounded parameters. Alternative
topologies could still fit the model, but would either have
more parameters or substantially deviate from the classical
linear model of hematopoiesis. Although we cannot rule
out these possibilities, we limited ourselves to the simpler
linear case. Furthermore, a revised modeling approach
will be needed to capture the behavior of aging HSPCs,
given that there are likely to be changes in the underlying
molecular processes that occur during aging, but are not
accommodated in our current model. Novel experimental
and computational approaches will be needed to ulti-
mately define HSC stem cell kinetics at single-cell
resolution.
Research over the past decade has revealed that hemato-
poieticmalignancies are commonly preceded by prolonged
periods of clonal hematopoiesis, where progeny from a sin-
gle stem/progenitor cell make up a significant proportion
of the entire blood system. Called either CHIP or ARCH,
it is now widely recognized that clonal hematopoiesis is
more the norm rather than the exception in aged individ-
uals (Busque et al., 2018). Clonal expansion is also a hall-
mark of full-blown malignancies, where the relationship
between ‘‘oncogene strength’’ and cell type of origin has
already been explored experimentally. Specifically, it was
shown that ‘‘stronger’’ oncogenes could transform more
downstream progenitors, whereas ‘‘weaker’’ oncogenes
needed to be introduced into the top tiers to cause malig-
nant transformation (as reviewed by Horton and Huntly,
2012). Moreover, the JAK2V617F mutation associated
with clonal hematopoiesis was shown to confer long-
term repopulation ability onto downstream progenitor
cells in a mouse model of myeloproliferative neoplasms
(Lundberg et al., 2014). Our computational model allowed
us to capture the dependence of oncogenic mutation
strength on the target cell for mutation, commonly
referred to in leukemia research as the ‘‘cell of origin.’’
Weak mutations are washed out of the system if they occur
in MPPs but cause sustained clonal expansion if they occur
in HSCs. Moreover, the relative increase in self-renewal ac-
tivity required to create an immortal MPP is small (1.06-
fold increase), suggesting that (1) MPPs may represent the
cell of origin for many leukemias due to their larger pool
size comparedwithHSCs, and (2)many experimental tech-
niques currently used will struggle to pick up such small
changes in self-renewal activity.
Perhaps it is not a surprise, therefore, that sampling
across the long time spans of human aging represents the
most robust ways to characterize clonal hematopoiesis so
far. However, studies relying on inferring clonal events
retrospectively from analysis of human patient samples
do not represent an experimentally tractable system. This
in turn suggests a real need for computationalmodeling ap-
proaches, based on abstractions of the hematopoietic sys-
tem that agree with experimental data across a range of
different laboratories. We hope that the work presented
here will stimulate further examination of both normal
and perturbed hematopoiesis.EXPERIMENTAL PROCEDURES
Steady-State Model Equations for Normal
Hematopoiesis
The same model as used in Busch et al. (2015) was applied to the
data obtained by Säwén et al. (2018). The model consisted of solv-
ing three ordinary differential equations using standardminimiza-
tion of the sum of weighted square residuals. Best-fit parameters
with 95% profile likelihood confidence bounds and the best-fit
model with 95% prediction profile likelihood confidence bounds
were inferred. Either standard error of the means or pooled vari-
ance was considered to weigh the squared residuals, but neither
produced a good model fit (Figure S1A).Non-Steady-State Model Equations for Normal
Hematopoiesis
The non-steady-state model used to fit both Tie2 and Fgd5 datasets
was adapted from Barile et al. (2020). As in Busch et al. (2015), the
expected number niðtÞ of cells in a population i in a linear pathway





=  ða1  b1Þ n1ðtÞ
dni>1ðtÞ
dt
=ai1 ni1ðtÞ  ðai  biÞ niðtÞ
: (Equation 1)
The parameters represent the cells’ fates, where for each popula-
tion, i represents the flux downstream and bi is defined as the net
proliferation rate, i.e., the difference of cell proliferation li and
death di:bi = li  di : (Equation 2)
These kinetic parameters were assumed shared for both datasets
and constant for the whole time frame. To understand the kinetics
more intuitively, the cell inverse residence time ki (inversely pro-
portional to the amount of time required for a population to
reduce to one-half of its initial size if the input is switched off)
was defined as:
ki = ai  bi: (Equation 3)
We assumed the labeled cells followed the same physiological
behavior as the unlabeled cells. Thus, the expected number of
labeled cells lA;iðtÞ for a reporter gene A in a given population i





=  k1 lA;1ðtÞ
dlA;i>1ðtÞ
dt
=ai1 lA; i1ðtÞ  ki lA;iðtÞ
: (Equation 4)
To reduce measurement noise, instead of the number of labeled
cells, the frequency fA;iðtÞ= lA;iðtÞniðtÞ of labeled cells was used with the












fA; i1ðtÞ  fA;iðtÞ
 : (Equation 5)
We defined the populations in upstream-to-downstreamorder as
HSC-U, HSC-D, ST-HSC, and MPP.
The initial conditions for Equation 1 (i.e., nið0Þ) and the initial
labeling frequency for each population and each reporter gene
(dataset) were additional parameters (i.e., fA;ið0Þ).
Data
The experimental datawere obtained fromBusch et al. (2015) (over
100 mice), Säwén et al. (2018) (over 50 mice), and Chapple et al.
(2018) (18 mice). The original Tie2 dataset was augmented by
further experimental data measured post-publication and
published in Barile et al. (2020) to improve precision. The time
frames of the three experiments were standardized so that they
could be compared directly. The measurement at time 0 was
adjusted to be the frequencies observed 2 days after tamoxifen
was assumed to have taken effect. For the Krt18 dataset, owing to
limited data points, time 0 was adjusted to be the frequencies
observed 1 day after tamoxifen was assumed to have taken effect.
To limit noisy variation from the Tie2 dataset, the data were
pooled to nearby time points as follows: 0–20 days (n = 41), 27–
50 days (n = 61), 55–69 days (n = 21), 78–95 days (n = 8), 104–
129 days (n = 39), 130–153 days (n = 34), 160–179 days (n = 21),
and 188–208 days (n = 17). The number of pooled categories was
chosen to be equal to the number of separate time points in the
Fgd5 dataset (n = 8). To obtain a consistent estimate of themeasure-
ment error, the variances were pooled for all the data points for all
the datasets to calculate the standard error of the mean.
Finally, for the non-steady-state model, the measurements of
compartment population size from Busch et al. (2015) and Säwén
et al. (2018) were combined, and the data were pooled into eight
categories (Figure S1B).Stem Cell Reports j Vol. 16 j 741–753 j April 13, 2021 751
Model Fit
See the Supplemental Experimental Procedures for details about
how fit was performed.
Leukemogenesis Dynamics
Using the model parameters (a; k;nð0Þ) derived from Equation 5,
the number of mutant cells miðtÞ in population i was assumed to





=  k1 m1ðtÞ
dmi>1ðtÞ
dt
=ai1 mi1ðtÞ  ki miðtÞ
: (Equation 8)
Amutation wasmodeled as a factor increase in proliferation rate,
such that amutation of31.03 would increase the cell proliferation
rate li to 1:03li for the mutated population and its downstream
progenitors. Differing strengths of proliferation rate increases
were applied to each population separately using the estimation
of death rates from Barile et al. (2020) and the aMPP estimate
from Busch et al. (2015).
The proportion of mutated MPPs pðtÞ obtained from a mutation







and obtaining the ratio:
pðtÞ = m4ðtÞ
n4ðtÞ : (Equation 10)
Last, the mutation required to induce an immortal MPP popula-
tion was calculated computationally by altering the proliferation
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Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K.,
Jensen, C.T., Bryder, D., Yang, L., Borge, O.J., Thoren, L.A.M., et al.
(2005). Identification of Flt3+ lympho-myeloid stem cells lacking
erythro-megakaryocytic potential: a revised road map for adult
blood lineage commitment. Cell 121, 295–306.
Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). A
clonogenic common myeloid progenitor that gives rise to all
myeloid lineages. Nature 404, 193–197.
Barile, M., Busch, K., Fanti, A.-K., Greco, A., Wang, X., Oguro, H.,
Zhang, Q., Morrison, S.J., Rodewald, H.-R., and Höfer, T. (2020).
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Schlenner, S.M., Reth, M., Höfer, T., and Rodewald, H.R. (2015).
Fundamental properties of unperturbed haematopoiesis from
stem cells in vivo. Nature 518, 542–546.
Busque, L., Buscarlet, M., Mollica, L., and Levine, R.L. (2018).
Concise review: age-related clonal hematopoiesis: stem cells
tempting the devil. Stem Cells 36, 1287–1294.
Cabezas-Wallscheid, N., Klimmeck, D., Hansson, J., Lipka, D.B.,
Reyes, A., Wang, Q.,Weichenhan, D., Lier, A., von Paleske, L., Ren-
ders, S., et al. (2014). Identification of regulatory networks in HSCs
and their immediate progeny via integrated proteome, transcrip-
tome, and DNA methylome analysis. Cell Stem Cell 15, 507–522.
Chapple, R.H., Tseng, Y.J., Hu, T., Kitano, A., Takeichi, M., Hoege-
nauer, K.A., andNakada,D. (2018). Lineage tracing ofmurine adult
hematopoietic stem cells reveals active contribution to steady-state
hematopoiesis. Blood Adv. 2, 1220–1228.
Foudi, A., Hochedlinger, K., van Buren, D., Schindler, J.W., Jae-
nisch, R., Carey, V., and Hock, H. (2009). Analysis of histone 2B-
GFP retention reveals slowly cycling hematopoietic stem cells.
Nat. Biotechnol. 27, 84–90.
Gazit, R.,Mandal, P.K., Ebina,W., Ben-Zvi, A., Nombela-Arrieta, C.,
Silberstein, L.E., and Rossi, D.J. (2014). Fgd5 identifies hematopoi-
etic stem cells in themurine bonemarrow. J. Exp. Med. 211, 1315–
1331.
Glauche, I., Cross, M., Loeffler, M., and Roeder, I. (2007). Lineage
specification of hematopoietic stem cells: mathematical modeling
and biological implications. Stem Cells 25, 1791–1799.
Grinenko, T., Arndt, K., Portz, M., Mende, N., Günther, M., Cos-
gun, K.N., Alexopoulou, D., Lakshmanaperumal, N., Henry, I.,
Dahl, A., et al. (2014). Clonal expansion capacity defines two
consecutive developmental stages of long-term hematopoietic
stem cells. J. Exp. Med. 211, 209–215.
Gunawardena, J. (2014). Models in biology: ‘‘Accurate descriptions
of our pathetic thinking. BMC Biol. 12, 29.
Hodgson, G.S., and Bradley, T.R. (1979). Properties of Haemato-
poietic stem cells surviving 5-Fluorouracil treatment: evidence
for a pre-CFU-S cell? [14]. Nature 281, 381–382.
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